Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer now shows Revision: v3.6.2, replacing Revision: v3.6.0; this reflects a platform update and does not change the study details displayed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdds a recruitment status notice stating that no participants are being recruited, signaling the study is closed to enrollment. Also introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the page revision from v3.5.5 to v3.6.0 with a formatting change to the Intervention/Treatment header.SummaryDifference0.4%

- Check25 days agoChange Detected- Revision tag updated from v3.5.4 to v3.5.5, signaling a small update to the page's documentation/metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision number was updated from v3.5.3 to v3.5.4, representing a deployment version change. No study content, data, or user-facing information was modified as part of this update.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, indicating a site or system version change rather than an update to the study record itself.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.